191 related articles for article (PubMed ID: 29175112)
1. Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms.
Karimi-Sales E; Mohaddes G; Alipour MR
Pharmacol Res; 2018 Mar; 129():177-187. PubMed ID: 29175112
[TBL] [Abstract][Full Text] [Related]
2. Cardamonin attenuates hyperalgesia and allodynia in a mouse model of chronic constriction injury-induced neuropathic pain: Possible involvement of the opioid system.
Sambasevam Y; Omar Farouk AA; Tengku Mohamad TA; Sulaiman MR; Bharatham BH; Perimal EK
Eur J Pharmacol; 2017 Feb; 796():32-38. PubMed ID: 27988285
[TBL] [Abstract][Full Text] [Related]
3. Escalation of liver malfunctioning: A step toward Herbal Awareness.
Sultana B; Yaqoob S; Zafar Z; Bhatti HN
J Ethnopharmacol; 2018 Apr; 216():104-119. PubMed ID: 29309862
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection.
García-Niño WR; Zazueta C
Pharmacol Res; 2015 Jul; 97():84-103. PubMed ID: 25941011
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adipocyte inflammation and macrophage chemotaxis by butein.
Wang Z; Lee Y; Eun JS; Bae EJ
Eur J Pharmacol; 2014 Sep; 738():40-8. PubMed ID: 24877688
[TBL] [Abstract][Full Text] [Related]
6. Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties.
Eichenberger M; Lehka BJ; Folly C; Fischer D; Martens S; Simón E; Naesby M
Metab Eng; 2017 Jan; 39():80-89. PubMed ID: 27810393
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
Hernández-Aquino E; Muriel P
World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
[TBL] [Abstract][Full Text] [Related]
8. Butein and Its Role in Chronic Diseases.
Song Z; Shanmugam MK; Yu H; Sethi G
Adv Exp Med Biol; 2016; 928():419-433. PubMed ID: 27671826
[TBL] [Abstract][Full Text] [Related]
9. The chalcones cardamonin and flavokawain B inhibit the differentiation of preadipocytes to adipocytes by activating ERK.
Zhang T; Yamamoto N; Yamashita Y; Ashida H
Arch Biochem Biophys; 2014 Jul; 554():44-54. PubMed ID: 24845100
[TBL] [Abstract][Full Text] [Related]
10. Chemical constituents of Morus alba L. and their inhibitory effect on 3T3-L1 preadipocyte proliferation and differentiation.
Yang Y; Yang X; Xu B; Zeng G; Tan J; He X; Hu C; Zhou Y
Fitoterapia; 2014 Oct; 98():222-7. PubMed ID: 25128426
[TBL] [Abstract][Full Text] [Related]
11. An update on the health benefits promoted by edible flowers and involved mechanisms.
Zheng J; Lu B; Xu B
Food Chem; 2021 Mar; 340():127940. PubMed ID: 32889216
[TBL] [Abstract][Full Text] [Related]
12. Chalcones suppress fatty acid-induced lipid accumulation through a LKB1/AMPK signaling pathway in HepG2 cells.
Zhang T; Yamamoto N; Ashida H
Food Funct; 2014 Jun; 5(6):1134-41. PubMed ID: 24722377
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP
Mejía SÁ; Gutman LAB; Camarillo CO; Navarro RM; Becerra MCS; Santana LD; Cruz M; Pérez EH; Flores MD
Eur J Pharmacol; 2018 Jan; 818():499-507. PubMed ID: 29069580
[TBL] [Abstract][Full Text] [Related]
15. A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway.
Fu Y; Ma J; Shi X; Song XY; Yang Y; Xiao S; Li J; Gu WJ; Huang Z; Zhang J; Chen J
Biochem Pharmacol; 2017 Jul; 135():126-138. PubMed ID: 28336257
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.
Bailly C; Vergoten G
Life Sci; 2020 Dec; 263():118601. PubMed ID: 33086122
[TBL] [Abstract][Full Text] [Related]
17. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies.
Liu DQ; Chen SP; Sun J; Wang XM; Chen N; Zhou YQ; Tian YK; Ye DW
Pharmacol Res; 2019 Oct; 148():104385. PubMed ID: 31400402
[TBL] [Abstract][Full Text] [Related]
18. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation.
Zheng ZG; Zhou YP; Zhang X; Thu PM; Xie ZS; Lu C; Pang T; Xue B; Xu DQ; Chen Y; Chen XW; Li HJ; Xu X
Biochem Pharmacol; 2016 Dec; 122():42-61. PubMed ID: 27816546
[TBL] [Abstract][Full Text] [Related]
19. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
20. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G
J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
